Novozymes acquired Delta Biotechnology, Ltd. from the Sanofi-Aventis Group as part of its strategy to extend its portfolio of products that are used as key ingredients in biopharmaceutical products. Delta, a wholly-owned subsidiary of Novozymes, operates as a self-contained business unit with both its R&D and manufacturing facilities based in Nottingham, UK. The new company will operate under the name Novozymes Delta Ltd. Novozymes Delta develops and manufactures recombina...